← Back to Search

Procedure

MRI Risk Maps for Prostate Cancer Diagnosis

N/A

Recruiting

Research Sponsored by University of Chicago

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 year

Awards & highlights

Study Summary

This trial looks at a software to analyze prostate images. Involves 1-2 biopsies, 1 MRI. Follow-up over 12 months.

Who is the study for?

This trial is for men who are suspected to have prostate cancer or already diagnosed and referred for an MRI of the prostate. They must be able to give written consent and follow study procedures. It's not open to those under 18, prisoners, anyone previously treated for prostate cancer, or with psychiatric disorders affecting consent.Check my eligibility

What is being tested?

Researchers are testing a new software tool designed to improve the analysis of MRI images of the prostate. The goal is to see if this Risk Map Decision Support System can help diagnose prostate cancer more accurately using targeted biopsy guided by MRI.See study design

What are the potential side effects?

Potential side effects may include discomfort from the MRI procedure, risks associated with biopsies like infection or bleeding, and possible anxiety related to undergoing diagnostic tests.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Decision Map Tool Compared to Oncologists

Trial Design

1Treatment groups

Experimental Treatment

Group I: All Participants (Single Arm)Experimental Treatment3 Interventions

All participants in this trial will be provided with routine instructions and precaution information before starting the magnetic resonance (MRI) scan. After the MRI, participants will undergo an MRI-guided fusion biopsy of the prostate as ordered by their doctor. During this prostate MRI-guided fusion biopsy, the research team will obtain tissue from up to two additional biopsy targets selected by the Risk Map DSS tool. Ultimately, the clinical radiologist will make the final decision on the targets to be biopsied.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Magnetic Resonance Imaging (MRI)

2015

Completed Phase 4

~1800

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of ChicagoLead Sponsor

1,004 Previous Clinical Trials

819,597 Total Patients Enrolled

20 Trials studying Prostate Cancer

8,103 Patients Enrolled for Prostate Cancer

Aytekin Oto, MDStudy ChairUniversity of Chicago Medicine Comprehensive Cancer Center

2 Previous Clinical Trials

149 Total Patients Enrolled

1 Trials studying Prostate Cancer

100 Patients Enrolled for Prostate Cancer

Media Library

Magnetic Resonance Imaging (MRI) Guided Biopsy (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT05710380 — N/A

Prostate Cancer Research Study Groups: All Participants (Single Arm)

Prostate Cancer Clinical Trial 2023: Magnetic Resonance Imaging (MRI) Guided Biopsy Highlights & Side Effects. Trial Name: NCT05710380 — N/A

Magnetic Resonance Imaging (MRI) Guided Biopsy (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05710380 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the capacity of participants for this clinical endeavor?

"Affirmative. In accordance with the information found on clinicaltrials.gov, this investigation is actively seeking individuals that meet its criteria for participation. This experiment was first posted in April of 2023 and last updated in June of the same year; 180 patients are being enrolled at a single location."

Answered by AI

Is enrollment still open for the clinical trial?

"Per the details on clinicaltrials.gov, this medical investigation is currently recruiting individuals for participation. Its initial posting was dated April 26th 2023 and it has recently been edited June 5th 2023."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy

2023. "MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05710380.

All > Prostate Cancer Chicago > Prostate Cancer